Gabapentin for the Reduction of Radiation Therapy Induced Pain During the Treatment of Oropharyngeal Cancer

NCT03269344 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Oropharynx Cancer

Interventions

DRUG: Gabapentin
DRUG: Placebo Oral Capsule

Sponsor

Henry Ford Health System